Published in Neurogastroenterol Motil on February 20, 2012
Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients (2012) 2.10
Mouse Paneth cell antimicrobial function is independent of Nod2. Gut (2013) 1.69
Altered profile of human gut microbiome is associated with cirrhosis and its complications. J Hepatol (2013) 1.68
Relationship Between Microbiota of the Colonic Mucosa vs Feces and Symptoms, Colonic Transit, and Methane Production in Female Patients With Chronic Constipation. Gastroenterology (2015) 1.56
Characterization of the fecal microbiota using high-throughput sequencing reveals a stable microbial community during storage. PLoS One (2012) 1.41
Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol (2013) 1.20
Intestinal microbiota in health and disease: role of bifidobacteria in gut homeostasis. World J Gastroenterol (2014) 1.19
Altered Colonic Bacterial Fermentation as a Potential Pathophysiological Factor in Irritable Bowel Syndrome. Am J Gastroenterol (2015) 1.14
Disruption of the human gut microbiota following Norovirus infection. PLoS One (2012) 1.13
The intestinal microbiome, probiotics and prebiotics in neurogastroenterology. Gut Microbes (2012) 1.12
Blastocystis is associated with decrease of fecal microbiota protective bacteria: comparative analysis between patients with irritable bowel syndrome and control subjects. PLoS One (2014) 1.06
Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: Part II - contemporary contextual research. Gut Pathog (2013) 1.05
Intestinal microbiota in healthy U.S. young children and adults--a high throughput microarray analysis. PLoS One (2013) 1.04
Gut microbiota as potential orchestrators of irritable bowel syndrome. Gut Liver (2015) 1.03
Fecal microbial diversity in pre-weaned dairy calves as described by pyrosequencing of metagenomic 16S rDNA. Associations of Faecalibacterium species with health and growth. PLoS One (2013) 1.03
Characterising the bacterial microbiota across the gastrointestinal tracts of dairy cattle: membership and potential function. Sci Rep (2015) 1.01
Why related bacterial species bloom simultaneously in the gut: principles underlying the 'Like will to like' concept. Cell Microbiol (2013) 0.98
Gut microbiota patterns associated with colonization of different Clostridium difficile ribotypes. PLoS One (2013) 0.98
Alterations of microbiota in urine from women with interstitial cystitis. BMC Microbiol (2012) 0.97
Altered enteric microbiota ecology in interleukin 10-deficient mice during development and progression of intestinal inflammation. Gut Microbes (2013) 0.97
Reduction of butyrate- and methane-producing microorganisms in patients with Irritable Bowel Syndrome. Sci Rep (2015) 0.96
The microbiota-gut-brain axis in functional gastrointestinal disorders. Gut Microbes (2014) 0.96
Colonization resistance: battle of the bugs or Ménage à Trois with the host? PLoS Pathog (2013) 0.96
Dysbiosis in the inflamed intestine: chance favors the prepared microbe. Gut Microbes (2014) 0.96
Rifaximin in irritable bowel syndrome: rationale, evidence and clinical use. Ther Adv Chronic Dis (2013) 0.95
Irritable bowel syndrome: a concise review of current treatment concepts. World J Gastroenterol (2014) 0.92
Gut Microbiota Diversity and Human Diseases: Should We Reintroduce Key Predators in Our Ecosystem? Front Microbiol (2016) 0.90
Molecular detection of bacterial contamination in gnotobiotic rodent units. Gut Microbes (2013) 0.90
Application of metagenomics in the human gut microbiome. World J Gastroenterol (2015) 0.90
Does the Urinary Microbiome Play a Role in Urgency Urinary Incontinence and Its Severity? Front Cell Infect Microbiol (2016) 0.89
Microbial population analysis of the salivary glands of ticks; a possible strategy for the surveillance of bacterial pathogens. PLoS One (2014) 0.89
Novel Testing Enhances Irritable Bowel Syndrome Medical Management: The IMMINENT Study. Glob Adv Health Med (2014) 0.89
Frequency of abnormal fecal biomarkers in irritable bowel syndrome. Glob Adv Health Med (2014) 0.88
Unraveling the ties between irritable bowel syndrome and intestinal microbiota. World J Gastroenterol (2014) 0.88
Modulation of the gut microbiota composition by rifaximin in non-constipated irritable bowel syndrome patients: a molecular approach. Clin Exp Gastroenterol (2015) 0.87
The Intestinal Microbiota in Acute Anorexia Nervosa and During Renourishment: Relationship to Depression, Anxiety, and Eating Disorder Psychopathology. Psychosom Med (2015) 0.87
Are probiotics or prebiotics useful in pediatric irritable bowel syndrome or inflammatory bowel disease? Front Med (Lausanne) (2014) 0.86
Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome. Int J Gen Med (2016) 0.86
Gut microbiota role in irritable bowel syndrome: New therapeutic strategies. World J Gastroenterol (2016) 0.85
High throughput sequencing reveals distinct microbial populations within the mucosal and luminal niches in healthy individuals. Gut Microbes (2015) 0.84
Recent developments in the pathophysiology of irritable bowel syndrome. World J Gastroenterol (2015) 0.84
The structures of the colonic mucosa-associated and luminal microbial communities are distinct and differentially affected by a prolonged murine stressor. Gut Microbes (2014) 0.83
Gut Microbiota Profiling: Metabolomics Based Approach to Unravel Compounds Affecting Human Health. Front Microbiol (2016) 0.83
Fecal protease activity is associated with compositional alterations in the intestinal microbiota. PLoS One (2013) 0.82
Refractory inflammatory bowel disease-could it be an irritable bowel? Nat Rev Gastroenterol Hepatol (2012) 0.82
Comparison of the bacterial composition and structure in symptomatic and asymptomatic endodontic infections associated with root-filled teeth using pyrosequencing. PLoS One (2013) 0.81
Overlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye? Therap Adv Gastroenterol (2016) 0.81
Stress and the microbiome: linking glucocorticoids to bacterial community dynamics in wild red squirrels. Biol Lett (2016) 0.80
Methodological issues in the study of intestinal microbiota in irritable bowel syndrome. World J Gastroenterol (2014) 0.80
Collateral damage: microbiota-derived metabolites and immune function in the antibiotic era. Cell Host Microbe (2014) 0.79
Effect of vitamin A and Zn supplementation on indices of vitamin A status, haemoglobin level and defecation of children with persistent diarrhea. J Clin Biochem Nutr (2016) 0.78
Germ-free mice as a model to study effect of gut microbiota on host physiology. Neurogastroenterol Motil (2014) 0.78
Fecal Microbiota Transplantation: A Review of Emerging Indications Beyond Relapsing Clostridium difficile Toxin Colitis. Gastroenterol Hepatol (N Y) (2015) 0.77
Clinical detection of human probiotics and human pathogenic bacteria by using a novel high-throughput platform based on next generation sequencing. J Clin Bioinforma (2014) 0.77
Effects of a high fat diet on intestinal microbiota and gastrointestinal diseases. World J Gastroenterol (2016) 0.77
Management Strategies for Abdominal Bloating and Distension. Gastroenterol Hepatol (N Y) (2014) 0.76
The microbiome of the oral mucosa in irritable bowel syndrome. Gut Microbes (2016) 0.76
Molecular characterization of the intestinal microbiota in patients with and without abdominal bloating. Am J Physiol Gastrointest Liver Physiol (2015) 0.76
Diagnosis and management of functional symptoms in inflammatory bowel disease in remission. World J Gastrointest Pharmacol Ther (2016) 0.75
Faecal biomarker patterns in patients with symptoms of irritable bowel syndrome. Frontline Gastroenterol (2016) 0.75
Metagenomics of two severe foodborne outbreaks provides diagnostic signatures and signs of co-infection not attainable by traditional methods. Appl Environ Microbiol (2016) 0.75
Can probiotics modulate human disease by impacting intestinal barrier function? Br J Nutr (2017) 0.75
Long-term use of ceftriaxone sodium induced changes in gut microbiota and immune system. Sci Rep (2017) 0.75
The Gut-Brain Axis in Healthy Females: Lack of Significant Association between Microbial Composition and Diversity with Psychiatric Measures. PLoS One (2017) 0.75
Can probiotics benefit children with autism spectrum disorders? World J Gastroenterol (2016) 0.75
Chronic Rhinosinusitis and Irritable Bowel Syndrome: A Case Report. Integr Med (Encinitas) (2016) 0.75
A tale of two sites: how inflammation can reshape the microbiomes of the gut and lungs. J Leukoc Biol (2016) 0.75
Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome. Gut Microbes (2016) 0.75
Dysbiosis of fecal microbiota and high frequency of Citrobacter, Klebsiella spp., and Actinomycetes in patients with irritable bowel syndrome and gastroenteritis. Gastroenterol Hepatol Bed Bench (2016) 0.75
The mucosal immune system: master regulator of bidirectional gut-brain communications. Nat Rev Gastroenterol Hepatol (2017) 0.75
Structural and functional alterations in the colonic microbiome of the rat in a model of stress induced irritable bowel syndrome. Gut Microbes (2017) 0.75
Repeat treatment with rifaximin improves irritable bowel syndrome-related quality of life: a secondary analysis of a randomized, double-blind, placebo-controlled trial. Therap Adv Gastroenterol (2017) 0.75
The role of Blastocystis sp. and Dientamoeba fragilis in irritable bowel syndrome: a systematic review and meta-analysis. Parasitol Res (2017) 0.75
Therapy of the postinfectious irritable bowel syndrome: an update. Clujul Med (2017) 0.75
Modeling a Superorganism - Considerations Regarding the Use of "Dirty" Mice in Biomedical Research . Yale J Biol Med (2017) 0.75
QIIME allows analysis of high-throughput community sequencing data. Nat Methods (2010) 85.34
Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol (2007) 60.97
A core gut microbiome in obese and lean twins. Nature (2008) 52.30
Search and clustering orders of magnitude faster than BLAST. Bioinformatics (2010) 51.97
UniFrac: a new phylogenetic method for comparing microbial communities. Appl Environ Microbiol (2005) 49.76
Diversity of the human intestinal microbial flora. Science (2005) 49.64
An obesity-associated gut microbiome with increased capacity for energy harvest. Nature (2006) 44.35
Error-correcting barcoded primers for pyrosequencing hundreds of samples in multiplex. Nat Methods (2008) 32.71
Host-bacterial mutualism in the human intestine. Science (2005) 26.39
Bacterial community variation in human body habitats across space and time. Science (2009) 24.84
Functional bowel disorders. Gastroenterology (2006) 20.72
Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Res (2011) 17.21
Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol (1999) 16.09
PyNAST: a flexible tool for aligning sequences to a template alignment. Bioinformatics (2009) 15.93
Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS One (2008) 14.63
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A (2008) 14.18
The influence of sex, handedness, and washing on the diversity of hand surface bacteria. Proc Natl Acad Sci U S A (2008) 12.99
Quantitative and qualitative beta diversity measures lead to different insights into factors that structure microbial communities. Appl Environ Microbiol (2007) 11.88
Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl Environ Microbiol (1998) 10.67
Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med (2011) 10.03
Phylogenetic relationships of butyrate-producing bacteria from the human gut. Appl Environ Microbiol (2000) 8.13
Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl Environ Microbiol (2002) 6.74
UniFrac: an effective distance metric for microbial community comparison. ISME J (2010) 6.43
A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology (2010) 5.29
Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis (2009) 4.72
An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol (2009) 3.99
The epidemiology of irritable bowel syndrome in North America: a systematic review. Am J Gastroenterol (2002) 3.59
The effects of alignment quality, distance calculation method, sequence filtering, and region on the analysis of 16S rRNA gene-based studies. PLoS Comput Biol (2010) 3.26
Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol (2005) 2.99
Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology (2011) 2.79
Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact. Aliment Pharmacol Ther (2005) 2.71
Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology (2011) 2.60
From structure to function: the ecology of host-associated microbial communities. Microbiol Mol Biol Rev (2010) 2.42
Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification. World J Gastroenterol (2009) 2.39
Health-related quality of life among persons with irritable bowel syndrome: a systematic review. Aliment Pharmacol Ther (2002) 1.97
Oligonucleotide probes that detect quantitatively significant groups of butyrate-producing bacteria in human feces. Appl Environ Microbiol (2003) 1.77
Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers. BMC Gastroenterol (2009) 1.76
A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence. Am J Gastroenterol (2006) 1.67
Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut (2005) 1.63
Costs of irritable bowel syndrome in the UK and US. Pharmacoeconomics (2006) 1.53
Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats. Am J Physiol Gastrointest Liver Physiol (2001) 1.51
Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol (2011) 1.49
Intestinal microecology and quality of life in irritable bowel syndrome patients. World J Gastroenterol (2004) 1.42
Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota. BMC Gastroenterol (2010) 1.41
The fecal microbial population in the irritable bowel syndrome. Microbiologica (1982) 1.40
Prevalence and temporal stability of selected clostridial groups in irritable bowel syndrome in relation to predominant faecal bacteria. J Med Microbiol (2006) 1.39
A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome. Dig Dis Sci (2009) 1.39
Neomycin improves constipation-predominant irritable bowel syndrome in a fashion that is dependent on the presence of methane gas: subanalysis of a double-blind randomized controlled study. Dig Dis Sci (2006) 1.24
Effect of abuse history on pain reports and brain responses to aversive visceral stimulation: an FMRI study. Gastroenterology (2007) 1.22
Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients. World J Gastroenterol (2009) 1.19
Microbial community and metabolomic comparison of irritable bowel syndrome faeces. J Med Microbiol (2011) 1.19
Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Gut Pathog (2010) 1.17
Review article: the psychoneuroimmunology of irritable bowel syndrome--an exploration of interactions between psychological, neurological and immunological observations. Aliment Pharmacol Ther (2008) 1.13
Alterations in the intestinal microbiota and functional bowel symptoms. Gastrointest Endosc Clin N Am (2009) 1.04
Altered intestinal microbiota in irritable bowel syndrome. Neurogastroenterol Motil (2010) 1.00
Interdigestive myoelectric complex in germ-free rats. Dig Dis Sci (1989) 1.00
Relationship between dietary-induced changes in intestinal commensal microflora and duodenojejunal myoelectric activity monitored by radiotelemetry in the rat in vivo. Exp Physiol (2005) 0.92
Bifidobacterium infantis 35624: a novel probiotic for the treatment of irritable bowel syndrome. Rev Gastroenterol Disord (2009) 0.85
Wireless pH-motility capsule for colonic transit: prospective comparison with radiopaque markers in chronic constipation. Neurogastroenterol Motil (2010) 1.29
Biofeedback treatment of fecal incontinence: a critical review. Dis Colon Rectum (2001) 0.93
Lactobacillus acidophilus NCFM affects colonic mucosal opioid receptor expression in patients with functional abdominal pain - a randomised clinical study. Aliment Pharmacol Ther (2014) 0.87
Continuous intravenous heparin administration in humans causes a decrease in serum lipolytic activity and accumulation of chylomicrons in circulation. J Lipid Res (1994) 0.82
Severe defect in clearing postprandial chylomicron remnants in dialysis patients. Kidney Int (1992) 0.81
Octogenarian subjects have low postprandial levels of chylomicron remnants: a possible explanation for protection against atherosclerosis. J Gerontol (1992) 0.80
The effects of dietary phospholipids enriched with phosphatidylethanolamine on bile and red cell membrane lipids in humans. Lipids (1996) 0.77
From gut to brain and back--a new perspective into functional gastrointestinal disorders. J Psychosom Res (1999) 0.77
One-week triple therapy with omeprazole, clarithromycin, and nitroimidazole for Helicobacter pylori infection in children and adolescents. Pediatrics (1998) 0.77
Metformin enhances clearance of chylomicrons and chylomicron remnants in nondiabetic mildly overweight glucose-intolerant subjects. Diabetes Care (1997) 0.77
Treatment of patients with functional esophageal symptoms: is there a role for a psychotherapeutic approach? J Clin Gastroenterol (1999) 0.75
A new method for the rapid measurement of cholesterol crystallization in model biles using a spectrophotometric microplate reader. J Lipid Res (1997) 0.75
Fluctuations of lipid and lipoprotein levels in hyperlipidemic postmenopausal women receiving hormone replacement therapy. Arch Intern Med (1998) 0.75